Indications and uses
to regrow hair on the top of the scalp (vertex only, see pictures on side of carton)
to regrow hair on the top of the scalp (vertex only, see pictures on side of carton)
• apply one mL with dropper 2 times a day directly onto the scalp in the hair loss area • using more or more often will not improve results • continues use is necessary to increase and keep your hair regrowth, or hair loss will begin again
Minoxidil 2% w/
Hair regrowth treatment
May be harmful if used when pregnant or breast-feeding.
If swallowed, get medical help or contact a Poison Control Center right away.
to regrow hair on the top of the scalp (vertex only, see pictures on side of carton)
For external use only
Flammable: Keep away from fire or flame
heart disease
alcohol (60% v/v), propylene glycol, purified water
If you have any questions, ask your healthcare professional or call us at 1-800-262-9010.
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| MINOXIDIL | ACTIVE INGREDIENT | 5965120SH1 | 4 | |
| MINOXIDIL | ACTIVE MOIETY | 5965120SH1 | 4 | |
| ALCOHOL | INACTIVE INGREDIENT | 3K9958V90M | 4 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | 4 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 4 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 50383-001 | 50383-001-02 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| MINOXIDIL | 5965120SH1 | ACTIB |
| ALCOHOL | 3K9958V90M | IACT |
| PROPYLENE GLYCOL | 6DC9Q167V3 | IACT |
| WATER | 059QF0KO0R | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| ALCOHOL | ALCOHOL | 3K9958V90M | PASTE / DENTAL | 1.8 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL, METERED / TOPICAL | 541 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION, CONCENTRATE / ORAL | 2590 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | FILM / BUCCAL | 1.48 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | DROPS / NASAL | 10 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / TOPICAL | 3633 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | LIQUID / RESPIRATORY (INHALATION) | 10 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / RESPIRATORY (INHALATION) | 35.75 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / TRANSDERMAL | 90 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL / TOPICAL | 561 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | FILM, EXTENDED RELEASE / TRANSDERMAL | 58.13 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAMUSCULAR | 1000 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | OINTMENT, AUGMENTED / TOPICAL | 714 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / RESPIRATORY (INHALATION) | 5 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | AEROSOL, FOAM / RECTAL | 1214 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVENOUS | 99 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | OINTMENT / RECTAL | 27 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION / ORAL | 22602 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | GEL / RECTAL | 3315 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SUSPENSION / AURICULAR (OTIC) | 10 %w/v | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | ELIXIR / ORAL | 9306 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | ELIXIR / ORAL | 13675 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SHAMPOO / TOPICAL | 714 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | AEROSOL / TOPICAL | 19.2 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / SUBLINGUAL | 397 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SUSPENSION / RECTAL | 0.35 %v/v | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SUSPENSION / TOPICAL | 5.28 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / SUBCUTANEOUS | 149 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SUSPENSION / RECTAL | 90400 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CAPSULE, COATED / ORAL | 25 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION/ DROPS / AURICULAR (OTIC) | ADJ PH | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SPRAY / SUBLINGUAL | 36 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET, FILM COATED / ORAL | 96 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CREAM / TOPICAL | 76000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, METERED / NASAL | 70 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / ORAL | 3563 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SPONGE / TOPICAL | 40 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE / ORAL | 882 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | OINTMENT / DENTAL | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY, METERED / SUBLINGUAL | 29 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SUSPENSION / ORAL | 681 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, EMULSION / INTRAVENOUS | 520 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION / DENTAL | 2 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | MOUTHWASH / BUCCAL | 200 mg/1ml | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | PASTE / DENTAL | 0.5 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET / ORAL | 64 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAVASCULAR | 100 %v/v | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | OINTMENT / TOPICAL | 5148 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SYSTEM / TOPICAL | 4200 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / TRANSDERMAL | 49.37 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / OPHTHALMIC | 0.5 %w/v | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET, COATED / ORAL | 16 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | DROPS / ORAL | 210 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / TOPICAL | 2445 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SPRAY / NASAL | 5 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / DENTAL | 1.8 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | INJECTION / SUBCUTANEOUS | 1.4 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / NASAL | 10 mg/1ml | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | LOTION / TOPICAL | 3392 mg |
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A074731-001 | MINOXIDIL (FOR MEN) | MINOXIDIL | 2% | SOLUTION / TOPICAL | 1996-12-24 | ||
| A074731-002 | MINOXIDIL (FOR WOMEN) | MINOXIDIL | 2% | SOLUTION / TOPICAL | 2005-05-11 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | A074731-001 | MINOXIDIL (FOR MEN) | 2% | SOLUTION / TOPICAL | 1996-12-24 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | A074731-002 | MINOXIDIL (FOR WOMEN) | 2% | SOLUTION / TOPICAL | 2005-05-11 | c2088c7a36db… | ||
| 2026-09-14 22:38:34 | 2026-08 | A074731-001 | MINOXIDIL (FOR MEN) | 2% | SOLUTION / TOPICAL | 1996-12-24 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A074731-002 | MINOXIDIL (FOR WOMEN) | 2% | SOLUTION / TOPICAL | 2005-05-11 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A074731-001 | MINOXIDIL (FOR MEN) | 2% | SOLUTION / TOPICAL | 1996-12-24 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A074731-002 | MINOXIDIL (FOR WOMEN) | 2% | SOLUTION / TOPICAL | 2005-05-11 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A074731-001 | MINOXIDIL (FOR MEN) | 2% | SOLUTION / TOPICAL | 1996-12-24 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A074731-002 | MINOXIDIL (FOR WOMEN) | 2% | SOLUTION / TOPICAL | 2005-05-11 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A074731-001 | MINOXIDIL (FOR MEN) | 2% | SOLUTION / TOPICAL | 1996-12-24 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A074731-002 | MINOXIDIL (FOR WOMEN) | 2% | SOLUTION / TOPICAL | 2005-05-11 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A074731-001 | MINOXIDIL (FOR MEN) | 2% | SOLUTION / TOPICAL | 1996-12-24 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A074731-002 | MINOXIDIL (FOR WOMEN) | 2% | SOLUTION / TOPICAL | 2005-05-11 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A074731-001 | MINOXIDIL (FOR MEN) | 2% | SOLUTION / TOPICAL | 1996-12-24 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A074731-002 | MINOXIDIL (FOR WOMEN) | 2% | SOLUTION / TOPICAL | 2005-05-11 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A074731-001 | MINOXIDIL (FOR MEN) | 2% | SOLUTION / TOPICAL | 1996-12-24 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A074731-002 | MINOXIDIL (FOR WOMEN) | 2% | SOLUTION / TOPICAL | 2005-05-11 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A074731-001 | MINOXIDIL (FOR MEN) | 2% | SOLUTION / TOPICAL | 1996-12-24 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A074731-002 | MINOXIDIL (FOR WOMEN) | 2% | SOLUTION / TOPICAL | 2005-05-11 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A074731-001 | MINOXIDIL (FOR MEN) | 2% | SOLUTION / TOPICAL | 1996-12-24 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A074731-002 | MINOXIDIL (FOR WOMEN) | 2% | SOLUTION / TOPICAL | 2005-05-11 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A074731-001 | MINOXIDIL (FOR MEN) | 2% | SOLUTION / TOPICAL | 1996-12-24 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A074731-002 | MINOXIDIL (FOR WOMEN) | 2% | SOLUTION / TOPICAL | 2005-05-11 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A074731-001 | MINOXIDIL (FOR MEN) | 2% | SOLUTION / TOPICAL | 1996-12-24 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A074731-002 | MINOXIDIL (FOR WOMEN) | 2% | SOLUTION / TOPICAL | 2005-05-11 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A074731-001 | MINOXIDIL (FOR MEN) | 2% | SOLUTION / TOPICAL | 1996-12-24 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A074731-002 | MINOXIDIL (FOR WOMEN) | 2% | SOLUTION / TOPICAL | 2005-05-11 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A074731-001 | MINOXIDIL (FOR MEN) | 2% | SOLUTION / TOPICAL | 1996-12-24 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A074731-002 | MINOXIDIL (FOR WOMEN) | 2% | SOLUTION / TOPICAL | 2005-05-11 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A074731-001 | MINOXIDIL (FOR MEN) | 2% | SOLUTION / TOPICAL | 1996-12-24 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A074731-002 | MINOXIDIL (FOR WOMEN) | 2% | SOLUTION / TOPICAL | 2005-05-11 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A074731-001 | MINOXIDIL (FOR MEN) | 2% | SOLUTION / TOPICAL | 1996-12-24 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A074731-002 | MINOXIDIL (FOR WOMEN) | 2% | SOLUTION / TOPICAL | 2005-05-11 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A074731-001 | MINOXIDIL (FOR MEN) | 2% | SOLUTION / TOPICAL | 1996-12-24 | 8072bd15b7f6… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A074731-002 | MINOXIDIL (FOR WOMEN) | 2% | SOLUTION / TOPICAL | 2005-05-11 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A074731-001 | MINOXIDIL (FOR MEN) | 2% | SOLUTION / TOPICAL | 1996-12-24 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A074731-002 | MINOXIDIL (FOR WOMEN) | 2% | SOLUTION / TOPICAL | 2005-05-11 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A074731-001 | MINOXIDIL (FOR MEN) | 2% | SOLUTION / TOPICAL | 1996-12-24 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A074731-002 | MINOXIDIL (FOR WOMEN) | 2% | SOLUTION / TOPICAL | 2005-05-11 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A074731-001 | MINOXIDIL (FOR MEN) | 2% | SOLUTION / TOPICAL | 1996-12-24 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A074731-002 | MINOXIDIL (FOR WOMEN) | 2% | SOLUTION / TOPICAL | 2005-05-11 | 4b0b4de00fa7… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 3bf4e467-d970-40a9-bf82-003f73d78808 | 1c548d51-6c30-4d82-a572-76f83f2d6a95 | 2022-05-31 | Warnings | 1c548d51-6c30-4d82-a572-76f83f2d6a95 |
Adverse event summaries are temporarily unavailable. Other product information remains available.